Cooper Companies (NASDAQ:COO) Shares Pass Above 200 Day Moving Average of $90.92

The Cooper Companies, Inc. (NASDAQ:COO) shares crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $90.92 and traded as high as $92.19. Cooper Companies shares last traded at $90.53, with a volume of 1,183,083 shares traded.

Analysts Set New Price Targets

Several research analysts have commented on the company. Mizuho lifted their price target on Cooper Companies from $102.50 to $115.00 and gave the stock a “buy” rating in a research report on Friday, March 1st. Stifel Nicolaus reiterated a “buy” rating and issued a $110.00 target price (up from $105.00) on shares of Cooper Companies in a research note on Friday, March 1st. Citigroup lifted their target price on Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. KeyCorp initiated coverage on Cooper Companies in a research note on Tuesday, February 6th. They issued a “sector weight” rating on the stock. Finally, TheStreet downgraded Cooper Companies from a “b-” rating to a “c” rating in a research note on Thursday, February 29th. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $109.48.

Cooper Companies Price Performance

The stock has a market capitalization of $17.99 billion, a price-to-earnings ratio of 61.90, a price-to-earnings-growth ratio of 2.37 and a beta of 0.94. The company has a 50 day moving average of $97.96 and a 200 day moving average of $90.92. The company has a quick ratio of 1.08, a current ratio of 1.86 and a debt-to-equity ratio of 0.35.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, February 29th. The medical device company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. Cooper Companies had a return on equity of 8.79% and a net margin of 7.93%. The firm had revenue of $931.60 million during the quarter, compared to analyst estimates of $915.93 million. During the same period in the prior year, the firm posted $2.90 earnings per share. The business’s quarterly revenue was up 8.5% compared to the same quarter last year. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 3.5 EPS for the current fiscal year.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, Director Gary S. Petersmeyer sold 1,000 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $103.51, for a total transaction of $103,510.00. Following the completion of the sale, the director now owns 5,668 shares of the company’s stock, valued at $586,694.68. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CAO Agostino Ricupati sold 54,724 shares of the company’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $100.89, for a total value of $5,521,104.36. Following the completion of the sale, the chief accounting officer now owns 5,081 shares of the company’s stock, valued at $512,622.09. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Gary S. Petersmeyer sold 1,000 shares of the company’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $103.51, for a total value of $103,510.00. Following the completion of the sale, the director now directly owns 5,668 shares of the company’s stock, valued at approximately $586,694.68. The disclosure for this sale can be found here. 2.00% of the stock is owned by company insiders.

Institutional Investors Weigh In On Cooper Companies

Several institutional investors and hedge funds have recently modified their holdings of COO. Vanguard Group Inc. boosted its holdings in Cooper Companies by 1.0% in the fourth quarter. Vanguard Group Inc. now owns 5,732,473 shares of the medical device company’s stock valued at $2,169,397,000 after purchasing an additional 56,911 shares during the last quarter. BlackRock Inc. raised its stake in Cooper Companies by 10.9% during the first quarter. BlackRock Inc. now owns 4,225,167 shares of the medical device company’s stock valued at $1,577,508,000 after buying an additional 416,807 shares in the last quarter. State Street Corp raised its stake in Cooper Companies by 0.5% during the first quarter. State Street Corp now owns 2,177,872 shares of the medical device company’s stock valued at $909,458,000 after buying an additional 10,373 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC raised its stake in Cooper Companies by 4.0% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,627,596 shares of the medical device company’s stock valued at $517,592,000 after buying an additional 62,345 shares in the last quarter. Finally, Moneta Group Investment Advisors LLC raised its stake in Cooper Companies by 102,613.9% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 1,385,611 shares of the medical device company’s stock valued at $458,180,000 after buying an additional 1,384,262 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.